HH most commonly presents in the neonatal period with the clinical presentation ranging from mild, moderate to severe medically unresponsive hypoglycemia (1).
Most patients in this study presented in shock with the mean shock index on presentation ranging from 1.2 to 1.3.
Jennifer Chayes, distinguished scientist and managing director of Microsoft Research New England, covered a wide span of different types of networks in her presentation — ranging from computational to biological — and discussed the key considerations for modeling any type of network.
The heterogeneity of this presentation, ranging from minor inconvenience to the patient, to a near incapacitating quality-of-life disturbance, as well as the wide range of treatment strategies, as is discussed in this article, certainly pose a challenge to the clinician.
The Journal welcomes alternative modes of presentation ranging from broad empirical analyses, to theoretical models, to case studies based on theoretical foundations.
The study included six males and three female patients with ages at presentation ranging from 26 to 68 months (mean age: 39.9 ± 15.2 months).
